| Views | |
|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 256 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 15 | 5 | 1 | 1 | 17 | 5 | 0 |
| Views | |
|---|---|
| 1-s2.0-S2211124721008500-main.pdf | 299 |
